Literature DB >> 31055769

Attenuation of Endoplasmic Reticulum Stress, Impaired Calcium Homeostasis, and Altered Bioenergetic Functions in MPP+-Exposed SH-SY5Y Cells Pretreated with Rutin.

Adaze Bijou Enogieru1, William Lloyd Haylett2,3, Hayley Christy Miller4, Francois Hendrikus van der Westhuizen4, Donavon Charles Hiss1, Okobi Eko Ekpo5.   

Abstract

Parkinson's disease (PD) is a common neurodegenerative disorder that affects approximately 1% of the population over the age of 65 years. While treatment options for PD are limited, reports show that plant-derived bioactive compounds such as rutin possess numerous pharmacological benefits, including antioxidant and antiapoptotic activities. This study aimed to investigate the potential role of rutin in MPP+-treated SH-SY5Y neuroblastoma cells, an established cell model of PD. Our findings reveal increased concentrations of Ca2+ and endoplasmic reticulum (ER) stress as well as impaired mitochondrial membrane potential and bioenergetic status in SH-SY5Y cells treated with MPP+ only. This is demonstrated by a significant reduction in the expression levels of BiP, significantly reduced basal respiration, maximal respiration, and spare respiratory capacity as well as a significant increase in the expression levels of CHOP; however, these effects were significantly attenuated following pretreatment with rutin. Also, rutin significantly improved basal and compensatory glycolysis as a response to an impaired oxidative phosphorylation system triggered by MPP+, characterized by deficient ATP production. In conclusion, our findings provide the first evidence on the ability of rutin to maintain Ca2+ homeostasis, inhibit ER stress, and protect the mitochondria in MPP+-treated SH-SY5Y cells.

Entities:  

Keywords:  ER stress; Glycolysis; Oxidative phosphorylation; Parkinson’s disease; Rutin

Mesh:

Substances:

Year:  2019        PMID: 31055769     DOI: 10.1007/s12640-019-00048-4

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  75 in total

1.  Arsenic induces reactive oxygen species-caused neuronal cell apoptosis through JNK/ERK-mediated mitochondria-dependent and GRP 78/CHOP-regulated pathways.

Authors:  Tien-Hui Lu; To-Jung Tseng; Chin-Chuan Su; Feng-Cheng Tang; Cheng-Chieh Yen; Yu-Yun Liu; Ching-Yao Yang; Chin-Ching Wu; Kuo-Liang Chen; Dong-Zong Hung; Ya-Wen Chen
Journal:  Toxicol Lett       Date:  2013-10-21       Impact factor: 4.372

2.  Chrysotoxine, a novel bibenzyl compound, inhibits 6-hydroxydopamine induced apoptosis in SH-SY5Y cells via mitochondria protection and NF-κB modulation.

Authors:  Ju-Xian Song; Pang-Chui Shaw; Cho-Wing Sze; Yao Tong; Xin-Sheng Yao; Tzi-Bun Ng; Yan-Bo Zhang
Journal:  Neurochem Int       Date:  2010-08-11       Impact factor: 3.921

Review 3.  Physiological phenotype and vulnerability in Parkinson's disease.

Authors:  D James Surmeier; Jaime N Guzman; Javier Sanchez; Paul T Schumacker
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

4.  Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons.

Authors:  William Andrew Holtz; Karen Laurel O'Malley
Journal:  J Biol Chem       Date:  2003-02-21       Impact factor: 5.157

5.  Calcium signaling and neurodegenerative diseases.

Authors:  Ilya Bezprozvanny
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

6.  MPP+ induces the endoplasmic reticulum stress response in rabbit brain involving activation of the ATF-6 and NF-kappaB signaling pathways.

Authors:  Othman Ghribi; Mary M Herman; Patcharin Pramoonjago; John Savory
Journal:  J Neuropathol Exp Neurol       Date:  2003-11       Impact factor: 3.685

7.  LKB1-regulated adaptive mechanisms are essential for neuronal survival following mitochondrial dysfunction.

Authors:  Marc Germain; Angela P Nguyen; Mireille Khacho; David A Patten; Robert A Screaton; David S Park; Ruth S Slack
Journal:  Hum Mol Genet       Date:  2012-11-27       Impact factor: 6.150

8.  MPP+ induces necrostatin-1- and ferrostatin-1-sensitive necrotic death of neuronal SH-SY5Y cells.

Authors:  Keisuke Ito; Yutaka Eguchi; Yusuke Imagawa; Shuji Akai; Hideki Mochizuki; Yoshihide Tsujimoto
Journal:  Cell Death Discov       Date:  2017-02-27

9.  Rutin mediated targeting of signaling machinery in cancer cells.

Authors:  Aliye Aras Perk; Iryna Shatynska-Mytsyk; Yusuf Can Gerçek; Kadir Boztaş; Mevzule Yazgan; Sundas Fayyaz; Ammad Ahmad Farooqi
Journal:  Cancer Cell Int       Date:  2014-11-30       Impact factor: 5.722

10.  Glycolysis, but not Mitochondria, responsible for intracellular ATP distribution in cortical area of podocytes.

Authors:  Shota Ozawa; Shuko Ueda; Hiromi Imamura; Kiyoshi Mori; Katsuhiko Asanuma; Motoko Yanagita; Takahiko Nakagawa
Journal:  Sci Rep       Date:  2015-12-18       Impact factor: 4.379

View more
  4 in total

1.  Regulation of AKT/AMPK signaling, autophagy and mitigation of apoptosis in Rutin-pretreated SH-SY5Y cells exposed to MPP.

Authors:  Adaze Bijou Enogieru; William Haylett; Donavon Charles Hiss; Okobi Eko Ekpo
Journal:  Metab Brain Dis       Date:  2020-11-04       Impact factor: 3.584

2.  Inhibition of γH2AX, COX-2 and regulation of antioxidant enzymes in MPP+-exposed SH-SY5Y cells pre-treated with rutin.

Authors:  Adaze Bijou Enogieru; William Haylett; Donavon Hiss; Okobi Ekpo
Journal:  Metab Brain Dis       Date:  2021-05-12       Impact factor: 3.584

3.  GSK2606414 attenuates PERK/p-eIF2α/ATF4/CHOP axis and augments mitochondrial function to mitigate high glucose induced neurotoxicity in N2A cells.

Authors:  Chayanika Gundu; Vijay Kumar Arruri; Bhoomika Sherkhane; Dharmendra Kumar Khatri; Shashi Bala Singh
Journal:  Curr Res Pharmacol Drug Discov       Date:  2022-01-24

Review 4.  The Endoplasmic Reticulum Stress/Unfolded Protein Response and Their Contributions to Parkinson's Disease Physiopathology.

Authors:  Cristine Alves da Costa; Wejdane El Manaa; Eric Duplan; Frédéric Checler
Journal:  Cells       Date:  2020-11-17       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.